Skip to main content
Intrasense logo

Intrasense — Investor Relations & Filings

Ticker · ALINS ISIN · FR0011179886 LEI · 969500VF6MOVQXWHAE33 PA Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 310 across all filing types
Latest filing 2017-11-16 Regulatory Filings
Country FR France
Listing PA ALINS

About Intrasense

https://www.intrasense.fr/

Intrasense, a subsidiary of the Guerbet Group, is a medical technology company that develops and markets advanced software solutions for medical imaging. Its flagship product, the Myrian® platform, is a comprehensive visualization tool that assists healthcare professionals in reviewing and analyzing 2D and 3D medical images from modalities such as MRI and CT scanners. The company's solutions are characterized by the native integration of Artificial Intelligence (AI) algorithms to enhance diagnostic accuracy and workflow efficiency. Intrasense also offers specialized solutions, including Liflow® for oncology imaging and the DUOnco™ suite of AI tools for lesion detection. The technology aims to facilitate and secure clinical diagnosis, decision-making, and therapeutic monitoring for radiologists and other clinicians.

Recent filings

Filing Released Lang Actions
Intrasense signe plusieurs partenariats majeurs pour Myrian® Studio
Regulatory Filings Classification · 95% confidence The document is a press release dated November 16, 2017, announcing the signing of several multi-year partnerships for Intrasense's Myrian® Studio offering with Quantib, 12 Sigma Technologies, and McGill University. It details the expected revenue impact ($2 million over two years) and confirms strategic direction. This type of announcement, focusing on business development, strategic partnerships, and expected revenue from new deals, does not fit the specific definitions for financial reports (10-K, IR, ER), management discussions (MDA), capital changes (CAP, SHA), or governance filings (DEF 14A, CGR). Since it is a specific business development announcement that is not a standard regulatory filing like a Director's Dealing (DIRS) or Major Shareholding (MRQ), and it is not a transcript (CT) or a formal presentation (IP), the most appropriate general category for a significant, non-standard corporate announcement is Regulatory Filings (RNS), which serves as a fallback for miscellaneous official announcements not covered elsewhere. Given the content is a specific business update rather than a general regulatory filing, and it is not a formal report, RNS is the best fit among the provided options for a press release detailing strategic business progress.
2017-11-16 French
Intrasense : rapport semestriel 2017
Interim / Quarterly Report Classification · 100% confidence The document is a 'Rapport Financier du Conseil d'Administration' (Board of Directors Financial Report) for the period ending June 30, 2017. It contains detailed financial performance data, including revenue, operating results, net loss, and cash position, as well as management's discussion of business activities and capital structure changes (OCABSA). Since it covers a period shorter than a full fiscal year (six months) and includes substantive financial statements and analysis, it is classified as an Interim/Quarterly Report. H2 2017
2017-11-01 French
Renforcement de la présence d’Intrasense en Chine : succès commerciaux et perspectives
Regulatory Filings Classification · 95% confidence The document announces specific business developments: the signing of a partnership with MinFound Medical Systems and the equipping of the City People Hospital in Lhassa, both aimed at strengthening commercial presence in China. It includes quotes from management (CEO and Deputy General Manager) discussing strategy and market potential. This content is characteristic of a press release or a general business update rather than a formal regulatory filing (like 10-K, IR, or ER) or a specific shareholder/governance document. Since it is a general announcement detailing business progress and strategic moves, it fits best under the 'Regulatory Filings' (RNS) category as a general corporate communication, or potentially an Earnings Release (ER) if it were tied to specific periodic results, but here it focuses on commercial expansion. Given the nature of announcing strategic partnerships and market penetration, and lacking specific financial period reporting or formal regulatory headers, RNS is the most appropriate general catch-all for significant, non-standard announcements, although it shares characteristics with an ER announcement summary. However, since it is not explicitly an 'Earnings Release' (ER) focusing on financial figures, and it is a general corporate update, RNS serves as the best fit among the provided options for a non-standard, material announcement.
2017-10-23 French
Intrasense strengthens its positions in China: sales success and perspectives
Regulatory Filings Classification · 95% confidence The document announces a significant business development: an exclusive partnership with a scanner manufacturer (MinFound Medical Systems) and securing a major hospital contract in China, leading to national coverage. It discusses revenue expectations and market strategy. This content is characteristic of a press release detailing strategic business progress, rather than a formal regulatory filing (like 10-K, IR, or AR) or a specific financial event announcement (like DIV or CAP). Since it is a general business update that doesn't fit the specific categories like M&A (TAR), Director's Dealing (DIRS), or Earnings Release (ER), it falls best under the general Regulatory Filings/Announcements category, which serves as a fallback for significant, non-standard corporate news. Given the nature of the announcement (strategic partnership and market expansion), it is most likely a general regulatory filing or press release that doesn't fit the highly specific financial codes. RNS is the most appropriate fallback for general corporate news releases.
2017-10-23 English
Intrasense et CGTR signent un partenariat au service de la télémédecine
Regulatory Filings Classification · 95% confidence The document is a press release dated October 18, 2017, announcing a partnership between Intrasense and CGTR regarding medical imaging solutions (Myrian®). It details the nature of the agreement, quotes executives, and provides background information on both companies. This type of announcement, detailing a significant business development (partnership/agreement) but not being a formal regulatory filing like a 10-K, ER, or IR, typically falls under general corporate news or investor relations material. Since there is no specific category for 'Partnership Announcement' and it is not a formal financial report, earnings release, or management discussion, it is best classified as a general Regulatory Filing (RNS) as a catch-all for significant, non-standard corporate news releases, or potentially Investor Presentation (IP) if it were structured as a deck, but here it reads like a news release. Given the context of financial reporting databases, press releases announcing strategic business moves often default to RNS if they don't fit ER, IR, or CAP. It is not a transaction (TAR), capital change (CAP/SHA), or director dealing (DIRS). RNS is the most appropriate fallback for a general corporate announcement.
2017-10-18 French
Intrasense and CGTR sign a partnership agreement serving telemedicine
M&A Activity Classification · 99% confidence The document is a press release dated October 18, 2017, announcing a new partnership agreement between Intrasense and CGTR regarding teleradiology solutions. It details the nature of the agreement, quotes executives, and provides background information on both companies. This type of announcement, which details a significant business development (a partnership/agreement) but is not a formal regulatory filing like a 10-K, earnings release, or capital change, fits best under the general category for business updates or regulatory announcements that don't fit elsewhere. Since it is a specific business development announcement (partnership), and not a standard financial report, it is classified as a Regulatory Filing (RNS) as the most appropriate general category, as there is no specific 'Partnership Announcement' code, and it is not a formal financial report or management discussion.
2017-10-18 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.